Xavier Mirabel, MD
Centre Oscar Lambret
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xavier Mirabel, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:19 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03408665 · Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver CancerCentre Oscar Lambret · active not recruiting · Liver Cancer, Liver Metastases · principal investigator
- N/ANCT02439008 · Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune ResponseCentre Oscar Lambret · terminated · Carcinoma, Hepatocellular, Colorectal Neoplasms, Melanoma · study director
- Ph2NCT02437656 · Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer.Centre Oscar Lambret · completed · Rectal Cancer · principal investigator
- Ph2NCT01318447 · CyberKnife® for Hepatic Metastases From Colorectal CancerAccuray Incorporated · terminated · Colorectal Liver Metastases · principal investigator
- Ph2NCT01165346 · Stereotaxic Irradiation of Hepatocellular CarcinomaCentre Oscar Lambret · completed · Hepatocellular Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.